SI3672968T1 - Trdna oblika ribociklib sukcinata - Google Patents

Trdna oblika ribociklib sukcinata

Info

Publication number
SI3672968T1
SI3672968T1 SI201831040T SI201831040T SI3672968T1 SI 3672968 T1 SI3672968 T1 SI 3672968T1 SI 201831040 T SI201831040 T SI 201831040T SI 201831040 T SI201831040 T SI 201831040T SI 3672968 T1 SI3672968 T1 SI 3672968T1
Authority
SI
Slovenia
Prior art keywords
solid state
state form
ribociclib succinate
ribociclib
succinate
Prior art date
Application number
SI201831040T
Other languages
English (en)
Inventor
Helena Ceric
Elisa Vergani
Paolo Simone Tiseni
Hana Kantor
Piero Paravidino
Nikolina Janton
Christian Galluzzo
Alexandr Jegorov
Original Assignee
Assia Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assia Chemical Industries Ltd filed Critical Assia Chemical Industries Ltd
Publication of SI3672968T1 publication Critical patent/SI3672968T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI201831040T 2017-08-25 2018-08-22 Trdna oblika ribociklib sukcinata SI3672968T1 (sl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762550208P 2017-08-25 2017-08-25
US201762555170P 2017-09-07 2017-09-07
US201762577446P 2017-10-26 2017-10-26
US201762593319P 2017-12-01 2017-12-01
EP18762743.5A EP3672968B1 (en) 2017-08-25 2018-08-22 Solid state form of ribociclib succinate
PCT/US2018/047434 WO2019040567A1 (en) 2017-08-25 2018-08-22 RIBOCICLIB SALTS AND SOLID STATE FORMS THEREOF

Publications (1)

Publication Number Publication Date
SI3672968T1 true SI3672968T1 (sl) 2024-03-29

Family

ID=63449728

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201831040T SI3672968T1 (sl) 2017-08-25 2018-08-22 Trdna oblika ribociklib sukcinata

Country Status (10)

Country Link
US (2) US11155545B2 (sl)
EP (2) EP4327880A3 (sl)
KR (1) KR102715956B1 (sl)
CA (1) CA3073936A1 (sl)
ES (1) ES2968174T3 (sl)
HR (1) HRP20240026T1 (sl)
IL (1) IL272859A (sl)
MX (1) MX2020002123A (sl)
SI (1) SI3672968T1 (sl)
WO (1) WO2019040567A1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9994579B2 (en) 2014-12-12 2018-06-12 Crystal Pharmatech Co., Ltd. Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt
CA3048036A1 (en) 2018-07-02 2020-01-02 Apotex Inc Novel crystalline form of ribociclib succinate
WO2020225827A1 (en) * 2019-05-08 2020-11-12 Mylan Laboratories Limited Novel polymorphs of ribociclib succinate
CN112010857B (zh) * 2019-05-30 2021-11-05 常州制药厂有限公司 一种瑞博西尼单丁二酸盐的晶型
CN112375081B (zh) * 2020-11-23 2022-04-12 中国医学科学院医药生物技术研究所 具有抑制CDK4、6或9活性的吡咯[2,3-d]嘧啶衍生物及其制备方法和应用
WO2022207788A2 (en) 2021-04-01 2022-10-06 Krka, D.D., Novo Mesto Process for the preparation of ribociclib and pharmaceutically acceptable salts thereof
WO2024115680A1 (en) 2022-12-01 2024-06-06 Krka, D.D., Novo Mesto Ribociclib salts and formulations thereof
WO2024201299A1 (en) 2023-03-27 2024-10-03 Novartis Ag Method of treating early breast cancer with ribociclib in combination with an aromatase inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685980B2 (en) 2008-08-22 2014-04-01 Novartis Ag Pyrrolopyrimidine compounds and their uses
AR083797A1 (es) 2010-11-10 2013-03-20 Novartis Ag Succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]pirimidin-6-carboxilico, proceso para prepararla, intermediarios de dicha sintesis y proceso de preparacion de los mismos
CN105111215B (zh) * 2014-12-12 2019-06-18 苏州晶云药物科技股份有限公司 一种周期蛋白依赖性激酶抑制剂的晶型及其制备方法
US9994579B2 (en) 2014-12-12 2018-06-12 Crystal Pharmatech Co., Ltd. Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt
EP3156406A1 (en) 2015-10-14 2017-04-19 ratiopharm GmbH Crystalline forms of ribociclib free base
WO2019150181A1 (en) * 2018-02-05 2019-08-08 Biophore India Pharmaceuticals Pvt Ltd Improved process for the preparation of 7-cyclopentyl-n, n-dimethyl-2-(5-(piperazin-1-yl) pyridin-2-ylaminuteso)-7h-pyrrolo[2,3-d] pyrimidine-6-carboxamide succinate (ribociclib succinate) and its crystalline forms thereof
TWI675662B (zh) * 2018-05-17 2019-11-01 中化合成生技股份有限公司 瑞博西尼琥珀酸鹽(Ribociclib succinate salt)晶型B、C及D與其衍生物,以及其等之製造方法與藥物組合物
US20230042479A1 (en) 2019-01-23 2023-02-09 Novartis Ag New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide

Also Published As

Publication number Publication date
KR20200074942A (ko) 2020-06-25
EP4327880A3 (en) 2024-05-22
WO2019040567A1 (en) 2019-02-28
KR102715956B1 (ko) 2024-10-10
US11155545B2 (en) 2021-10-26
HRP20240026T1 (hr) 2024-03-29
EP4327880A2 (en) 2024-02-28
US20220041598A1 (en) 2022-02-10
US20200190084A1 (en) 2020-06-18
ES2968174T3 (es) 2024-05-08
EP3672968B1 (en) 2023-11-01
MX2020002123A (es) 2020-09-18
CA3073936A1 (en) 2019-02-28
IL272859A (en) 2020-04-30
EP3672968A1 (en) 2020-07-01

Similar Documents

Publication Publication Date Title
ZA201904500B (en) Separate configuration of numerology-associated resources
IL272888A (en) Uses of piperidinyl-indole derivatives
SG11201706729SA (en) Derivatives of sobetirome
IL257026A (en) Solid state forms of eluxadoline
GB201706477D0 (en) Modification of polypeptides
SI3672968T1 (sl) Trdna oblika ribociklib sukcinata
IL263050B (en) History of Subtirum
IL269409A (en) Combinations of chk1- and wee1 - inhibitors
IL268731A (en) New uses of anti-SIRPG antibodies
IL274627A (en) Solid forms of valbenazine
IL265628A (en) Solid state forms of valbenazine
SI3154526T1 (sl) Trdne oblike sofosbuvira
EP3201424A4 (en) Deployment of expandable graphite
IL246979A0 (en) Crystalline forms of sofosbuvir
ZA201706282B (en) Solid forms of menaquinols
IL272857A (en) Cofanalisib formulations
IL263673A (en) Solid state forms of spiro-oxindole compounds
IL274494A (en) Esters of dihydrotetrabenazine
EP3721889A4 (en) USE OF DEBUTYRIBACTER INTESTINI
PT3678644T (pt) Formulações de copanlisib
IL254666A0 (en) Crystalline forms of Aldecalcitol
GB201719981D0 (en) Unwinding of materials
IL283421A (en) Crystalline forms of Refroxlap
GB201721386D0 (en) Chrondogy of time-wave
AU2017904670A0 (en) Improvement of clothes-hangers